These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38026572)

  • 1. Reference on copy number variations in pleomorphic xanthoastrocytoma: Implications for diagnostic approach.
    Reuss DE; Schrimpf D; Stichel D; Ebrahimi A; Dampier C; Aldape K; Snuderl M; Capper D; Sill M; Jones DTW; Pfister SM; Sahm F; von Deimling A
    Free Neuropathol; 2023 Jan; 4():. PubMed ID: 38026572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival.
    Ebrahimi A; Korshunov A; Reifenberger G; Capper D; Felsberg J; Trisolini E; Pollo B; Calatozzolo C; Prinz M; Staszewski O; Schweizer L; Schittenhelm J; Harter PN; Paulus W; Thomas C; Kohlhof-Meinecke P; Seiz-Rosenhagen M; Milde T; Casalini BM; Suwala A; Wefers AK; Reinhardt A; Sievers P; Kramm CM; Etminam N; Unterberg A; Wick W; Herold-Mende C; Sturm D; Pfister SM; Sill M; Jones DTW; Schrimpf D; Reuss DE; Aldape K; Abdullaev Z; Sahm F; von Deimling A; Stichel D
    Acta Neuropathol Commun; 2022 Jan; 10(1):5. PubMed ID: 35012690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation.
    Vaubel RA; Caron AA; Yamada S; Decker PA; Eckel Passow JE; Rodriguez FJ; Nageswara Rao AA; Lachance D; Parney I; Jenkins R; Giannini C
    Brain Pathol; 2018 Mar; 28(2):172-182. PubMed ID: 28181325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of DNA methylation profiles and copy number alterations in 10782 adult-type glioblastomas, IDH-wildtype.
    Reuss DE; Schrimpf D; Cherkezov A; Suwala AK; Lausová T; Snuderl M; Capper D; Sill M; Jones DTW; Pfister SM; Sahm F; von Deimling A
    Free Neuropathol; 2024 Jan; 5():. PubMed ID: 38532825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?
    Vaubel R; Zschernack V; Tran QT; Jenkins S; Caron A; Milosevic D; Smadbeck J; Vasmatzis G; Kandels D; Gnekow A; Kramm C; Jenkins R; Kipp BR; Rodriguez FJ; Orr BA; Pietsch T; Giannini C
    Brain Pathol; 2021 Jan; 31(1):20-32. PubMed ID: 32619305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Insights into Pediatric Pleomorphic Xanthoastrocytoma through DNA Methylation Class and Pathological Diagnosis Analysis.
    Alturkustani M
    Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.
    Phillips JJ; Gong H; Chen K; Joseph NM; van Ziffle J; Bastian BC; Grenert JP; Kline CN; Mueller S; Banerjee A; Nicolaides T; Gupta N; Berger MS; Lee HS; Pekmezci M; Tihan T; Bollen AW; Perry A; Shieh JTC; Solomon DA
    Brain Pathol; 2019 Jan; 29(1):85-96. PubMed ID: 30051528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MGMT Promoter Methylation and BRAF V600E Mutations Are Helpful Markers to Discriminate Pleomorphic Xanthoastrocytoma from Giant Cell Glioblastoma.
    Lohkamp LN; Schinz M; Gehlhaar C; Guse K; Thomale UW; Vajkoczy P; Heppner FL; Koch A
    PLoS One; 2016; 11(6):e0156422. PubMed ID: 27253461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Histomorphologic/Molecular Association and Immune Checkpoint Regulators in Epithelioid Glioblastoma and Pleomorphic Xanthoastrocytoma: Are These Tumors Potential Candidates for Immune Checkpoint Blockade?
    Mahajan S; Singh J; Dandapath I; Jha P; Chaturvedi S; Ahuja A; Bhardwaj M; Saran R; Garg A; Sharma MC; Manjunath N; Suri A; Sarkar C; Suri V
    Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):84-95. PubMed ID: 38158760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide DNA methylation profiling shows molecular heterogeneity of anaplastic pleomorphic xanthoastrocytoma.
    Nakamura T; Fukuoka K; Nakano Y; Yamasaki K; Matsushita Y; Yamashita S; Ikeda J; Udaka N; Tanoshima R; Shiba N; Tateishi K; Yamanaka S; Yamamoto T; Hirato J; Ichimura K
    Cancer Sci; 2019 Feb; 110(2):828-832. PubMed ID: 30609203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleomorphic xanthoastrocytoma, anaplastic pleomorphic xanthoastrocytoma, and epithelioid glioblastoma: Case series with clinical characteristics, molecular features and progression relationship.
    Lin Z; Yang R; Zheng H; Li Z; Yi G; Wu Q; Yang C; Huang G
    Clin Neurol Neurosurg; 2022 Oct; 221():107379. PubMed ID: 35932588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma.
    Furuta T; Miyoshi H; Komaki S; Arakawa F; Morioka M; Ohshima K; Nakada M; Sugita Y
    Neuropathology; 2018 Jun; 38(3):218-227. PubMed ID: 29532523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleomorphic xanthoastrocytoma with anaplastic features: A rare case report and review of literature with reference to current management.
    Patibandla MR; Nayak M; Purohit AK; Thotakura AK; Uppin M; Challa S
    Asian J Neurosurg; 2016; 11(3):319. PubMed ID: 27366280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular landscape of IDH-wild-type, H3-wild-type glioblastomas of adolescents and young adults.
    Shi ZF; Li KK; Huang QJ; Wang WW; Kwan JS; Chen H; Liu XZ; Li WC; Chan DT; Zhang ZY; Mao Y; Ng HK
    Neuropathol Appl Neurobiol; 2022 Jun; 48(4):e12802. PubMed ID: 35191072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant transformation of pleomorphic xanthoastrocytoma and differential diagnosis: case report.
    Watanabe N; Ishikawa E; Kohzuki H; Sakamoto N; Zaboronok A; Matsuda M; Shibuya M; Matsumura A
    BMC Neurol; 2020 Jan; 20(1):21. PubMed ID: 31941461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation alterations in grade II- and anaplastic pleomorphic xanthoastrocytoma.
    Martínez R; Carmona FJ; Vizoso M; Rohde V; Kirsch M; Schackert G; Ropero S; Paulus W; Barrantes A; Gomez A; Esteller M
    BMC Cancer; 2014 Mar; 14():213. PubMed ID: 24650279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rare Case Report of Intraventricular Anaplastic Pleomorphic Xanthoastrocytoma.
    Bettencourt S; Almeida G; Maia T
    Cureus; 2023 Mar; 15(3):e35975. PubMed ID: 37041907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular features of pleomorphic xanthoastrocytoma.
    Zou H; Duan Y; Wei D; Zhang Y; Dai J; Li J; Li X; Zhou J; Liu Z; Jin Z; Zhang Z; Yu Y; Hu Z
    Hum Pathol; 2019 Apr; 86():38-48. PubMed ID: 30496796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic Pleomorphic Xanthoastrocytoma: A Rare Variant of Astrocytoma.
    Alshantti K; Nadarajan C; Mijol MM; Mat Zin AA
    Cureus; 2022 Mar; 14(3):e23060. PubMed ID: 35464510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF V600E, TERT, and IDH2 Mutations in Pleomorphic Xanthoastrocytoma: Observations from a Large Case-Series Study.
    Ma C; Feng R; Chen H; Hameed NUF; Aibaidula A; Song Y; Wu J
    World Neurosurg; 2018 Dec; 120():e1225-e1233. PubMed ID: 30240866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.